Skip to main content

Suarez-Calvet, M., Kleinberger, G., Araque Caballero, M. A., Brendel, M., Rominger, A., Alcolea, D., Fortea, J., Lleo, A., Blesa, R., Gispert, J. D., Sanchez-Valle, R., Antonell, A., Rami, L., Molinuevo, J. L., Brosseron, F., M., & Haass, C., et al. (2016). sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers. EMBO Mol Med, 8, 466-476